BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35491955)

  • 1. Prodromal X-Linked Dystonia-Parkinsonism is Characterized by a Subclinical Motor Phenotype.
    Steinhardt J; Hanssen H; Heldmann M; Sprenger A; Laabs BH; Domingo A; Reyes CJ; Prasuhn J; Brand M; Rosales R; Münte TF; Klein C; Westenberger A; Oropilla JQ; Diesta C; Brüggemann N
    Mov Disord; 2022 Jul; 37(7):1474-1482. PubMed ID: 35491955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP).
    Mertin R; Diesta C; Brüggemann N; Rosales RL; Hanssen H; Westenberger A; Steinhardt J; Heldmann M; Manalo HTS; Oropilla JQ; Klein C; Helmchen C; Sprenger A
    J Neurol; 2023 Sep; 270(9):4262-4275. PubMed ID: 37191726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal Ganglia Atrophy as a Marker for Prodromal X-Linked Dystonia-Parkinsonism.
    Hanssen H; Diesta CCE; Heldmann M; Dy J; Tantianpact J; Steinhardt J; Sauza R; Manalo HTS; Sprenger A; Reyes CJ; Tuazon R; Laabs BH; Domingo A; Rosales RL; Klein C; Münte TF; Westenberger A; Oropilla JQ; Brüggemann N
    Ann Neurol; 2023 May; 93(5):999-1011. PubMed ID: 36646669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor assessment of X-linked dystonia parkinsonism via machine-learning-based analysis of wearable sensor data.
    Parisi F; Corniani G; Bonato P; Balkwill D; Acuna P; Go C; Sharma N; Stephen CD
    Sci Rep; 2024 Jun; 14(1):13229. PubMed ID: 38853162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral diadochokinetic markers of X-linked dystonia-parkinsonism.
    Kao TH; Rowe HP; Green JR; Stipancic KL; Sharma N; de Guzman JK; Supnet-Wells ML; Acuna P; Perry BJ
    Parkinsonism Relat Disord; 2024 Mar; 120():105991. PubMed ID: 38184995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism.
    Goto S; Lee LV; Munoz EL; Tooyama I; Tamiya G; Makino S; Ando S; Dantes MB; Yamada K; Matsumoto S; Shimazu H; Kuratsu J; Hirano A; Kaji R
    Ann Neurol; 2005 Jul; 58(1):7-17. PubMed ID: 15912496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism.
    Arasaratnam CJ; Singh-Bains MK; Waldvogel HJ; Faull RLM
    Neurobiol Dis; 2021 Jan; 148():105186. PubMed ID: 33227492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia and cerebellar pathology in X-linked dystonia-parkinsonism.
    Hanssen H; Heldmann M; Prasuhn J; Tronnier V; Rasche D; Diesta CC; Domingo A; Rosales RL; Jamora RD; Klein C; Münte TF; Brüggemann N
    Brain; 2018 Oct; 141(10):2995-3008. PubMed ID: 30169601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers.
    Prasuhn J; Henkel J; Algodon SM; Uter J; Rosales RL; Klein C; Steinhardt J; Diesta CC; Brüggemann N
    Mov Disord Clin Pract; 2024 May; 11(5):550-555. PubMed ID: 38404049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked dystonia Parkinsonism: crossing a new threshold.
    Ng AR; Jamora RDG; Rosales RL
    J Neural Transm (Vienna); 2021 Apr; 128(4):567-573. PubMed ID: 33721107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding Data Collection for the MDSGene Database: X-linked Dystonia-Parkinsonism as Use Case Example.
    Pauly MG; Ruiz López M; Westenberger A; Saranza G; Brüggemann N; Weissbach A; Rosales RL; Diesta CC; Jamora RDG; Reyes CJ; Madoev H; Petkovic S; Ozelius LJ; Klein C; Domingo A
    Mov Disord; 2020 Nov; 35(11):1933-1938. PubMed ID: 32949450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Network Imaging Biomarker of X-Linked Dystonia-Parkinsonism.
    Niethammer M; Tang CC; Jamora RDG; Vo A; Nguyen N; Ma Y; Peng S; Waugh JL; Westenberger A; Eidelberg D
    Ann Neurol; 2023 Oct; 94(4):684-695. PubMed ID: 37376770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
    Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
    Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration.
    Sprenger A; Hanssen H; Hagedorn I; Prasuhn J; Rosales RL; Jamora RDG; Diesta CC; Domingo A; Klein C; Brüggemann N; Helmchen C
    Parkinsonism Relat Disord; 2019 Apr; 61():170-178. PubMed ID: 30352750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic alteration of substantia nigra is related to parkinsonism-predominant course of X-linked dystonia-parkinsonism.
    Walter U; Rosales R; Rocco A; Westenberger A; Domingo A; Go CL; Brüggemann N; Klein C; Lee LV; Dressler D
    Parkinsonism Relat Disord; 2017 Apr; 37():43-49. PubMed ID: 28094105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism.
    Alonto AHD; Jamora RDG
    Parkinsonism Relat Disord; 2024 Feb; 119():105949. PubMed ID: 38072720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Linked Parkinsonism: Phenotypic and Genetic Heterogeneity.
    Di Lazzaro G; Magrinelli F; Estevez-Fraga C; Valente EM; Pisani A; Bhatia KP
    Mov Disord; 2021 Jul; 36(7):1511-1525. PubMed ID: 33960519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
    Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
    Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Vaine CA; Shin D; Liu C; Hendriks WT; Dhakal J; Shin K; Sharma N; Bragg DC
    Neurobiol Dis; 2017 Apr; 100():108-118. PubMed ID: 28017799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
    Chin HL; Lin CY; Chou OH
    Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.